Clinitech Laboratory Limited is coming up with an IPO consisting of a fresh issue of 6,02,400 shares worth INR 5.78 crores. The company aims to expand diagnostic centers and meet general corporate purposes.
Clinitech Laboratory IPO – Important Dates
| Clinitech Laboratory Limited IPO Date | July 25, 2024 to July 29, 2024 |
| Clinitech Laboratory Limited IPO Listing Date | August 1, 2024 |
| Clinitech Laboratory Limited IPO Price | INR 96 per share |
| Clinitech Laboratory Limited IPO Lot Size | 1200 shares |
| Clinitech Laboratory Limited IPO Total Issue Size | INR 5.78 crores |
| Clinitech Laboratory Limited IPO Basis of Allotment | July 30, 2024 |
| Clinitech Laboratory Limited IPO Initiation of Refunds | July 31, 2024 |
| Clinitech Laboratory Limited IPO Credit of Shares to Demat | July 31, 2024 |
| Clinitech Laboratory Limited IPO Issue Type | Fixed Price Issue IPO |
| Clinitech Laboratory Limited IPO Listing At | BSE SME |
Clinitech Laboratory Limited IPO – Company Profile
Clinitech Laboratory Limited provides diagnostic and healthcare tests and services through 8 Thane and Navi Mumbai centers. Promoters have over 30 years of experience in the diagnostic business.
With over 3 lakh tests conducted annually, NABL-accredited labs at Clinitech Laboratory Limited are equipped with modern technology and high-end equipment.
More than 150 tests are conducted at Clinitech centers, classified under Biochemistry, Immunology, Hematology, Molecular Biology, Serology, Microbiology, and Histopathology.
Clinitech Laboratory Ltd IPO Fundamental Analysis
Clinitech Laboratory Limited Technologies’ financial analysis reveals a mixed performance. Revenue decreased year-on-year, but equity increased while debt reliance dropped. Profitability and EPS fell sharply as RoNW, inventory turnover decreased, and assets and the current ratio increased.
- Revenue Trend: The revenue decreased from ₹638.43 lakhs in March 2022 to ₹634.75 lakhs in March 2023. The revenue for the current year’s 6-month period ending September 2023 is INR 305.81 lakhs.
- Equity and Liabilities: Equity has consistently increased over the periods, reflecting potential growth and expansion. However, the debt-equity ratio has decreased, indicating reduced reliance on debt financing.
- Profitability: The profit after tax (PAT) has significantly decreased from ₹51.26 lakhs in March 2022 to ₹6.78 lakhs by September 2023.
- Earnings per Share (EPS): The diluted EPS has reduced from ₹3.42 in March 2022 to ₹0.45 by September 2023.
- Return on Net Worth (RoNW): The RoNW has reduced from 27.74% to 2.77%, indicating a decrease in the company’s ability to generate returns on shareholder equity.
- Financial Position: Total assets have increased, suggesting potential business growth. However, the current ratio has increased, indicating strengthening liquidity and potential challenges in meeting short-term obligations.
- Inventory Turnover Ratio: There’s a significant decrease in the Inventory Turnover Ratio, which might suggest slower sales or inefficient inventory management.
Clinitech Laboratory IPO Financial Analysis
| Particular | As of 31 March 2022 | As of 31 March 2023 | As of 30 September 2023 |
| Revenue (₹ in lakhs) | 638.43 | 634.75 | 305.81 |
| Equity (₹ in lakhs) | 184.81 | 238.08 | 244.86 |
| Expenses (₹ in lakhs) | 531.78 | 499.65 | 278.56 |
| Profit and Loss After Tax (₹ in lakhs) | 51.26 | 61.31 | 6.78 |
| Diluted EPS only (₹) | 3.42 | 4.09 | 0.45 |
| Return on Net Worth (%) | 27.74 | 25.75 | 2.77 |
| NAV per Equity Share (₹) | 12.32 | 15.87 | 16.32 |
| Total Assets (in lakhs) | 368.74 | 603.33 | 467.43 |
| Total Liabilities (in lakhs) | 183.93 | 365.26 | 222.57 |
| Debt Equity Ratio | 0.47 | 0.41 | 0.33 |
| Current Ratio (in times) | 1.05 | 1.20 | 1.19 |
| Inventory Turnover Ratio | 11.82 | 7.85 | 3.42 |
Clinitech Laboratory Limited IPO Peer Comparison
Clinitech Laboratory Limited shows modest figures across various metrics. Dr. Lalpath Labs Limited excels with high performance, while Thyrocare Limited and Krsnaa Diagnostics Limited also demonstrate strong results with notable variances in profitability and returns.
| Company | Total Revenue (₹ in lakhs) | Face Value per Equity Share (₹) | P/E Ratio | EPS (₹) | RoNW (%) | NAV per Equity Share (₹ in lakhs) |
| Clinitech Laboratory Limited | 636.00 | 10 | 23.49 | 4.09 | 27.74 | 15.87 |
| Dr Lalpath Labs Limited | 205,860 | 10 | 84.26 | 29.12 | 715.53 | 203.91 |
| Thyrocare Limited | 63,509 | 10 | 55.16 | 12.16 | 12.02 | 101.12 |
| Krsnaa Diagnostics Limited | 50,650 | 5 | 35.85 | 19.78 | 8.41 | 235.28 |
Clinitech Laboratory Ltd IPO Objective
The main objective of Clinitech Laboratory Limited is to expand diagnostic centers.
- Expansion of Diagnostic Centres: The company intends to utilize INR 4.98 crores for 15 new diagnostic centers in Navi Mumbai to Panvel.
- General Corporate Purposes: The company will deploy the balance funds of INR 41.33 lakhs towards general corporate expenses, including funding growth opportunities, strategic initiatives, joint ventures, partnerships, marketing, business development, facility expansion, and meeting contingencies.
Clinitech Laboratory IPO Risks And Challenges
Clinitech Laboratory Limited’s risks include maintaining its brand reputation, adapting to service quality changes, and having a regional concentration in Thane and Navi Mumbai. These factors could lead to negative publicity, operational impacts, and financial challenges.
- The company’s success relies on its brand reputation and the quality and efficiency of its diagnostic services. Errors, delays, misinterpretations, or operational mishaps could harm patients, lead to negative publicity, and impact operations and finances.
- Quality of services is crucial; meeting diverse customer expectations safeguards their cash flow. Rapid changes in technology or service standards and failure to adapt could negatively impact their business, operations, and financial condition.
- The concentration of operations in Thane and Navi Mumbai exposes them to risks such as regional natural disasters, policy changes, limited diversification, and perception as a regional player, which could impact their business and strategy.
Clinitech Laboratory Ltd IPO – Industry & Market Potential
The Indian diagnostic industry, valued at INR 675 billion, is increasing at a 10% CAGR. Despite fragmentation, organized players with asset-light models and national presence are set to thrive, driven by volume and competitive pricing.
The diagnostic market is split into unorganized (47%), hospital-based labs (37%), and organized players (~16%). Doctor referrals, often involving commission payments, are significant. Currently, illness diagnosis dominates wellness in India.
India’s diagnostic industry, leveraging economies of scale, has strong growth potential. Established national chains with global standards and extensive networks are well-positioned for expansion, driven by increasing preventive healthcare awareness and growing insurance coverage.
Clinitech Laboratory Limited IPO – Type of Offer
Clinitech Laboratory Limited is coming up with an IPO consisting of a fresh issue of 6,02,400 shares worth INR 5.78 crores. The company aims to expand diagnostic centers and meet general corporate purposes.
Clinitech Laboratory IPO Offer Size
The offer size of Clinitech Laboratory Limited is 5.78 crores, consisting of a fresh issue of 6,02,400 shares. The company seeks funds to expand diagnostic centers and meet general corporate purposes.
Clinitech Laboratory Limited IPO Allotment Structure
Clinitech Laboratory Limited’s IPO allotment structure includes a category for Retail Individual Investors (RII) with investments below ₹2 lakhs, a category for other investors exceeding ₹2 lakhs, and a reservation of 31,200 shares for Market Makers.
- Retail Individual Investors (RII): These individual investors apply for shares with a total value of less than Rs.2 lakhs.
- Other than retail individual investors: Such applications where the value exceeds INR 2 lakhs.
- Market Makers Reservation: A certain percentage or number of shares is reserved for market makers. The company has set aside 31,200 shares for this purpose.
How to apply for a Clinitech Laboratory Limited IPO?
To apply for the Clinitech Laboratory Limited IPO through Alice Blue, you would typically follow these steps:
Open a Demat and Trading Account: If you don’t have one already, you must open a Demat and trading account with Alice Blue.
- Check for IPO Details: Once your account is active, you can check for the Clinitech Laboratory Limited IPO details in the IPO section of the Alice Blue platform.
- Place the Bid: Enter the number of shares you wish to buy and place your bid within the IPO’s price band.
- Submit the Application: Confirm all your details and submit your application.
You can apply for the Clinitech Laboratory Limited IPO at Alice Blue in just a few clicks!
Check Allotment Status: After the allotment process, you can check the allotment status to see if you have received any shares.
Please note that the allotment of shares is not guaranteed and will depend on the demand for the IPO.
How do you check Clinitech Laboratory Limited’s IPO Allotment Status?
Checking the allotment status of an IPO in Alice Blue is usually straightforward. Please follow these general steps:
- Log in to your Alice Blue Account: You can do this through the Alice Blue website or their trading app.
- Navigate to the Portfolio or IPO Section: This might differ based on the layout of Alice Blue’s platform, but generally, you can find the status of your IPO application under the ‘Portfolio’ or ‘IPO’ section.
- Find the IPO Allotment Status: Look for a sub-section called ‘IPO Allotment Status’ or something similar. This is where you can see the status of the IPOs you have applied for.
- Select the Clinitech Laboratory Limited IPO: If you have applied for multiple IPOs, there might be a dropdown menu or a list where you can select the IPO you are interested in. Select the Clinitech Laboratory Limited IPO.
- Check the Status: The status of your application should be displayed here. If the shares have been allocated to you, it would be mentioned here.
If you face any issues, it’s recommended that you contact Alice Blue’s customer support for detailed assistance.
Apart from Alice Blue, there are other ways to check the allotment status of the Clinitech Laboratory Limited IPO:
● Registrar’s Website: Visit the website of Bigshare Services Private Limited, the registrar of the Clinitech Laboratory Limited IPO. On the homepage, look for the ‘IPO Allotment Status’ option. You must enter your PAN, application, or Demat account number to check your allotment status. Click on the ‘Submit’ button to view your IPO allotment status.
● BSE SME: You can also check the allotment status on the official websites of the Bombay Stock Exchange (BSE) Small Medium Exchange (SME). You would need your application number and PAN to check the status.
Please note that the allotment status will only be available after completing the allotment process, a few days after the IPO window closes.
Clinitech Laboratory Limited Ltd IPO Offer Registrar
The registrar for the Clinitech Laboratory Limited IPO is Bigshare Services Private Limited. They are responsible for ensuring the IPO allotment and refund processes are carried out smoothly.
Contact information for the registrar:
BIGSHARE SERVICES PRIVATE LIMITED
S6-2, 6th Floor, Pinnacle Business Park,
Mahakali Caves Road, Next to Ahura Centre,
Andheri East, Mumbai – 400 093, Maharashtra, India
Tel. No.: +91 22 6263 8200
Email: [email protected]
Website: www.bigshareonline.com
Clinitech Laboratory Limited Limited IPO – FAQs
1. What is Clinitech Laboratory Limited’s allotment date?
The allotment date of the Clinitech Laboratory Limited IPO is July 30, 2024.
2. What is the price band of the Clinitech Laboratory Limited IPO?
The price band of the issue is INR 96 per share.
3. What is the size of the Clinitech Laboratory Limited IPO?
The offer size of Clinitech Laboratory Limited is 5.78 crores, consisting of a fresh issue of 6,02,400 shares. The company seeks funds to expand diagnostic centers and meet general corporate purposes.
4. What is the listing date of the Clinitech Laboratory Limited IPO?
The listing date of Clinitech Laboratory Limited’s IPO is August 1, 2024.
